Drugs / MSP1 42-C1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00320658 | Mar 2006 → Jul 2007 | malaria | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSP1(42)-C1 | “FVO and 3D7 recombinant proteins of MSP1(42) were mixed (MSP1(42)-C1).” PMID 20107498 ↗ Jan 2010 |
| Modality | Vaccine | “MSP1 42-C1 is a malaria vaccine” NCT00320658 ↗ |
| Route | Intramuscular | “3 vaccinations with a dose of 40 mcg MSP1 42-C1/Alhydrogel given into the deltoid muscle of either arm.” NCT00320658 ↗ |